Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.4.1, replacing Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T22:38:10.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:36:46.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision was updated from v3.3.3 to v3.3.4, which appears to be metadata and does not modify study content, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:07:08.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T20:33:21.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The Publications section adds a note that publications are provided voluntarily by the entrant and pertain to study results, and the revision label changes from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:21:56.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Deleted the administrative funding/operating status notice banner from the page. Core study information such as the title, conditions, interventions, eligibility criteria, and outcomes remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:14:02.000Z thumbnail image

Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.